Vanguard Capital Management
EXOZ

Vanguard Capital Management’s eXoZymes Inc EXOZ Stock Holding History

Vanguard Capital Management’s Portfolio EXOZ Stock Details EXOZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$464K Buy
54,985
+32,795
+148% +$309K ﹤0.01% 3722
2026
Q1 		$166K Buy
+22,190
New +$203K ﹤0.01% 3818

Other funds holding EXOZ

DKCM
Davidson Kahn Capital Management Sherman Oaks, California $233M AUM 19.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $80B AUM 26.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Vanguard Capital Management's EXOZ Position: Q2 2026 in Review

Vanguard Capital Management increased its eXoZymes Inc (EXOZ) stake by 148% in Q2 2026, buying an estimated $309K and bringing the position to 54,985 shares worth $464K. The position accounts for ﹤0.01% of the portfolio, ranked #3722.

Vanguard Capital Management first reported a position in EXOZ in Q1 2026 and has held it in 2 quarters since. 10 funds tracked by Wall St. Rank hold EXOZ as of Q2 2026.

  • Vanguard Capital Management held 54,985 shares of eXoZymes Inc worth $464K as of Q2 2026.
  • Vanguard Capital Management bought 32,795 eXoZymes Inc shares in Q2 2026, an estimated $309K.
  • eXoZymes Inc made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3722 holding.
  • Vanguard Capital Management first reported a position in eXoZymes Inc in Q1 2026 and has held it in 2 quarters since.
  • 10 funds tracked by Wall St. Rank held eXoZymes Inc as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.